Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

0
Player Avatar MadisonClub1 (< 20) Submitted: 11/22/2006 8:11:36 PM : Outperform Start Price: $8.35 ENZN Score: -24.29

All looks bad for it but ....just a feeling

Featured Broker Partners


Advertisement